|
|
|
Potential first-line treatment for advanced cSCC
|
|
The epidermal growth factor (EGFR) inhibitor cetuximab achieved good outcomes in patients with advanced SCC, according to results of a recent study. |
|
|
|
App may improve adolescent sun protection behavior
|
|
A recently published study in JAMA Dermatology showcases positive results for a face aging app’s effect on adolescent skin cancer protection behavior. |
